VR Logo

ARCA biopharma Inc. (ABIO) download report


Healthcare | Biotechnology & Pharma Research

ARCA biopharma Inc. (ABIO) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases.

IPO Date: 08-Aug-1997

Co-Founder, Pres, CEO & Director: Dr. Michael R. Bristow M.D., Ph.D.

Chief Operating Officer: Mr. Thomas A. Keuer

Listing: NASDAQ: ABIO

Country: United States

Headquarters: Westminster, CO

Website: https://www.arcabio.com

Key Facts

Market cap: $34.87 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-16.68 Mln

Cash: $46.44 Mln

Total Debt: $0.33 Mln

Insider's Holding: 0.74%

Liquidity: Low

52 Week range: $1.71 - 3.17

Shares outstanding: 14,410,100

10 Years Aggregate:

  • CFO: $-101.30 Mln
  • EBITDA: $-109.76 Mln
  • Net Profit: $-109.80 Mln

Stock Performance

Time Period ARCA biopharma (ABIO) S&P BSE Sensex S&P Small-Cap 600
YTD13.952.08-8.13
1 month-2.009.3214.13
3 months7.469.9412.23
1 Year-19.419.05-5.78
3 Years-26.3816.5311.43
5 Years-37.7013.769.16
10 Years-37.2112.9711.05
As on 12-Aug-2022
Year ARCA biopharma (ABIO) S&P Small-Cap 600 S&P BSE Sensex
2021-46.3825.2721.99
2020-29.789.5715.75
2019-4.8720.8614.38
2018-75.11-9.705.87
2017-52.6311.7327.91
2016-38.7124.741.95
2015-30.34-3.36-5.03